Latest papers

Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.

Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?

An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pig model.

Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between doses.

Effect of human rotavirus vaccine on severe diarrhea in African infants.

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency.

Rotavirus vaccine--a powerful tool to combat deaths from diarrhea.

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.

Prevention and treatment of viral diarrhea in pediatrics.

[More severe bacterial infections could be prevented with vaccine. Rotavirus, influenza and varicella cause thousands of hospital admissions].

Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.

Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.

Impact of rotavirus vaccination: the importance of monitoring strains.

Update on Rotarix: an oral human rotavirus vaccine.

Rotavirus disease and vaccination: impact on genotype diversity.

Should rotavirus vaccines be included in the national immunization program of a small developed country?

Retrospective surveillance for intussusception in children aged less than five years in a South Indian tertiary-care hospital.

Rotavirus vaccination.

12th Annual Conference on Vaccine Research.

Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009.